115 related articles for article (PubMed ID: 24024535)
1. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
Ferren T; Palmes GK; Kaplan SG
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
[No Abstract] [Full Text] [Related]
2. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
Teeuwisse JM; Nolen WA
Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
[No Abstract] [Full Text] [Related]
3. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
Korkmaz S; Işik U; Korkmaz H
Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344
[No Abstract] [Full Text] [Related]
4. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
[No Abstract] [Full Text] [Related]
5. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
da Rocha FF; Correa H
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
[No Abstract] [Full Text] [Related]
6. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy].
Todorov C
Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568
[TBL] [Abstract][Full Text] [Related]
7. [Novel treatment strategies for refractory patients with obsessive-compulsive disorder].
Nakamae T
Seishin Shinkeigaku Zasshi; 2013; 115(9):997-1003. PubMed ID: 24228478
[TBL] [Abstract][Full Text] [Related]
8. Treatment of obsessive compulsive neurosis: pharmacological approach.
Ananth J
Psychosomatics; 1976; 17(4):180-4. PubMed ID: 12532
[No Abstract] [Full Text] [Related]
9. Biological factors in obsessive-compulsive disorders.
Turner SM; Beidel DC; Nathan RS
Psychol Bull; 1985 May; 97(3):430-50. PubMed ID: 2860681
[No Abstract] [Full Text] [Related]
10. Step-wise Drug Therapy for Comorbid Bipolar and Obsessive-Compulsive Disorders.
Naguy A; Alrashidi F
Am J Ther; 2019; 26(5):e668-e670. PubMed ID: 30418229
[No Abstract] [Full Text] [Related]
11. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.
Skapinakis P; Papatheodorou T; Mavreas V
Eur Neuropsychopharmacol; 2007 Jan; 17(2):79-93. PubMed ID: 16904298
[TBL] [Abstract][Full Text] [Related]
12. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
Zink M; Knopf U; Kuwilsky A
Aust N Z J Psychiatry; 2007 Mar; 41(3):293-4. PubMed ID: 17464712
[No Abstract] [Full Text] [Related]
13. Use of atypical antipsychotics in refractory depression and anxiety.
Nemeroff CB
J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacologic treatment of obsessive-compulsive disorder.
Thorneloe WF
J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
[No Abstract] [Full Text] [Related]
15. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
Rubio G; Jiménez-Arriero MA; Martínez-Gras I; Manzanares J; Palomo T
J Clin Psychopharmacol; 2006 Jun; 26(3):341-4. PubMed ID: 16702907
[No Abstract] [Full Text] [Related]
16. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
Denys D; van Megen HJ; Westenberg HG
Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
18. Early-onset schizophrenia and obsessive-compulsive disorder in a young man with Dandy-Walker variant.
Papazisis G; Mastrogianni A; Karastergiou A
Schizophr Res; 2007 Jul; 93(1-3):403-5. PubMed ID: 17478081
[No Abstract] [Full Text] [Related]
19. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
Kawahara T; Ueda Y; Mitsuyama Y
Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
[TBL] [Abstract][Full Text] [Related]
20. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
Salmerón JM; Alcántara AG; Barcia D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
